Skip to main content
. 2020 Dec 22;13:13097–13109. doi: 10.2147/OTT.S286627

Figure 2.

Figure 2

The association between MIR205HG and clinical features of ESCC patients. (A) The results of the ROC analysis of MIR205HG in ESCC. (B) The si-MIR205HG#2 and si-MIR205HG #3 suppressed MIR205HG expression in KYSE30 and EC109 cells. (C) MIR205HG knockdown inhibited KYSE30 cell proliferation. (D) The cell growth rate of the EC109 cell was reduced when silencing of MIR205HG. **P<0.01, ***P<0.001.